摘要
目的:
通过研究己烯雌酚对体外培养的雌激素受体阳性人乳腺癌MCF-7细胞中的WISP-2基因表达的影响,以雌二醇作对照,探讨己烯雌酚在乳癌发生中的作用;研究MCF-7细胞株WISP-2基因对BCL-2基因的影响,探讨两个基因在抑制癌细胞凋亡、促进癌细胞增殖过程中的作用。
方法:
采用MTT法检测己烯雌酚对MCF-7细胞生长活性的影响。运用免疫细胞化学方法和逆转录-聚合酶链反应方法检测己烯雌酚对体外培养的人乳腺癌细胞MCF-7中WISP-2mRNA和WISP-2蛋白表达影响,并以雌二醇作阳性对照组。运用免疫细胞化学方法检测人乳癌细胞MCF-7中WISP-2蛋白表达变化时BCL-2的蛋白表达状况。
结果:
1)己烯雌酚使MCF-7增殖率增加。
2)己烯雌酚作用于MCF-7细胞使WISP-2mRNA和WISP-2蛋白表达上升,高浓度的己烯雌酚的效应高于低浓度的己烯雌酚的效应。WISP-2mRNA和蛋白表达随己烯雌酚作用时间的延长而增加,其效应与雌二醇类似。
3)用反义核苷酸抑制乳癌细胞MCF-7中WISP-2蛋白的表达后,BCL-2蛋白表达降低。
结论:
1) 己烯雌酚能促进MCF-7细胞增殖。
2) 己烯雌酚能诱导MCF-7细胞中的WISP-2基因表达增加,作用强度随
Object:l)To explore the effects of diethylstilbestrol on the expression of the WISP-2 gene in human breast cancer cell line MCF-7,and to compare its effect with 17- β estradiol. The research is to study the role of diethylstilbestrol in the development of human breast cancer, and its mechanism.2)To explore the effects of WISP-2 gene on the expression of the BCL-2 gene in human breast cancer cell line MCF-7. The research is to study the role of them in the inhibition of cell apoptosis and acceleration of cell proliferation .Methods:MCF-7 cell were cultured in vitro, and exposed to various concentrations of diethylstilbestrol in the different time, the expression of WISP-2 mRNA and its protein were measured using RT-PCR and immunohistochemistry approach. The experiment set up vacuity negative control , and 17-β estradiol positive control, the expression of BCL-2 protein was measured using immunohistochemistry approach when the expression of WISP-2 protein changed in the MCF-7 cell. To detect the proliferation was using MTT approach.Results:1) Diethylstilbestrol accelerated the MCF-7 cell proliferation.2) Exposed to diethylstilbestrol, expression of WISP-2 mRNA and its protein was increased. The effect of high concentration diethylstilbestrol was
引文
[1] 杜克久,徐晓白.环境雌激素研究进展.科学通报,2000,45(21):2241～2249.
[2] 刘先利,刘彬,邓南圣.环境内分泌干扰物研究进展.上海环境科学,2003,22(1):57～61.
[3] Jacobs HS. Hormone replacement therapy and breast cancer. Endocr Relat Cancer, 2000, 7(1): 53～61.
[4] Retha R, Newbold, Rita B, Hanson et al. Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis, 2000, 21(7): 1355-1363.
[5] Mclachlan J A. Functional toxicology: a new approach to detect biologically active xenobiotics. Environmental Health Perspectives. 1993, 101(2): 386～387.
[6] Colborn T, vom saal F S, Soto A M. Developmental effects of endocrine-disruption chemical. Environmental Health Perspectives. 1993, 101(2): 378～384.
[7] Hidekuni Inadera, Shin-ichi Hashimoto, et al. Wisp-2 as a novel estrogen-responsive gene in human breast cancer cells. Biochem Biophys Res Commun. 2000, 275(1): 108～114.
[8] Bork P. The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 1993, 327(1): 125～130.
[9] Inadera H. Estrogen-induced genes, WISP-2 and pS2, respond divergently to protein kinase pathway. Biochem Biophys Res Commun. 2003, 309(2): 272～278.
[10] Banerjee S, Saxena N, Sengupta K, et al. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia. 2003, 5(1): 63～73.
[11]Zoubine MN, Banerjee S, Saxena NK, et al. WISP-2:a serum-inducible gene differentially expressed in human normal breast epithelial cells and in MCF-7 breast tumor cells. Biochem Biophys Res Commun, 2001,282(2):421~425.
[12]Matthew E ,Yan Tang et al. Effects of environmental estrogens on tumor necrosis factor α-mediated apoptosis in MCF-7 cells. Carcinogenesis, 1999, 20(11):2057~2061.
[13]Stephen W Tobin, Mary Kay Brown et al. Inhibition of transforming growth factor β signaling in MCF-7cells results in resistance to tumor necrosis factor a: a role of bcl-2. Cell growth and differentiation,2001, 12(2): 109~117.
[14]Keiichi H, Barry S.O, Felix C.T,et al. Connective Tissue Growth Factor Induces Apoptosis in Human Breast Cancer Cell Line MCF-7. THE Journal OF Biological Chemistry,1999 274(52) :37461~37466.
[15]Fawell J K, Wilkinson M J. Oestrogenic substances in water. a review. J Water SRT-Aqua,1994,43(1): 219~221.
[16]Shore L S. Estrogen as a environmental pollutant. Bull Environ Contam toxicol 1993,51 (3):361~366.
[17]Thomas A G, Jemal A, Thun M J. Breast Cancer Facts and Figures 2001 - 2002. American Cancer Society, USA, pp 1~ 20.
[18]Delmolino LM, Stearns NA, Castellot JJ 1997 Heparin induces a novel member of the CCN family which has characteristics of a growth arrest gene. Mol Biol Cell [Suppl] ,8:A1665 (Abstract).
[19] Zhang R, Averboukh L, Zhu W,et al. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol, 1998 ,18(10):6131~6141.
[20]Almendral JM, Sommer D, MacDonald-Bravo H, et al. Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol, 1988,8(5):2140~2148.
[21]Bradham DM, Igarashi A, Potter RL, et al. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991,114(6): 1285-1294.
[22]Lau LF, Nathans D . Identification of a set of genes expressed during the G0/G1 transition of cultured mouse cells. EMBO J 1985, 14(12):3145~3151.
[23]Jay P, Berge'-Lefranc JL, Marsollier C, et al. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene 1997,14(14): 1753~1757.
[24]Joliot V, Martinerie C, Dambrine G, et al. Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus Type 1-induced nephroblastomas. Mol Cell Biol , 1992 ,12(1): 10~21.
[25]Martinerie C, Huff V, Joubert I, et al. Structural analysis of the human nov protooncogene and expression in Wilms tumors. Oncogene 1994,9(9):2729~2732.
[26]Martinerie C, Perbal B. Expression of a gene encoding a novel potential IGF binding protein in human tissues. C R Acad Sci III, 1991,313(8):345~351.
[27]Hashimoto Y, Shindo-Okada N, Tani M, et al. Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display. Cancer Res, 1996,56(22):5266~5271.
[28]Hashimoto Y, Shindo-Okada N, Tani M, et al. Expression of the lml gene, a novel gene of the CCN (connective tissue growth factor, cyr61/ cef-10 and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med,1998 ,187(3):289~296.
[29]Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated